miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction
暂无分享,去创建一个
Ting Huyan | Qi Li | N. Gao | Xiaojie Zhou | Chaochao Wang | Lina Gao | W. Guo
[1] S. Andò,et al. A novel phage display based platform for exosome diversity characterization. , 2022, Nanoscale.
[2] J. Olefsky,et al. Exosomes as mediators of intercellular crosstalk in metabolism. , 2021, Cell metabolism.
[3] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[4] Ting Huyan,et al. Extracellular Vesicles – Advanced Nanocarriers in Cancer Therapy: Progress and Achievements , 2020, International journal of nanomedicine.
[5] Hong Ma,et al. MiR‐221‐5p is involved in the regulation of inflammatory responses in acute gouty arthritis by targeting IL‐1β , 2020, International journal of rheumatic diseases.
[6] Mengzhao Zhang,et al. The role of exosomal miR‐375‐3p: A potential suppressor in bladder cancer via the Wnt/β‐catenin pathway , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Annelisa M Cornel,et al. MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy , 2020, Cancers.
[8] W. Olejarz,et al. Tumor-Derived Exosomes in Immunosuppression and Immunotherapy , 2020, Journal of immunology research.
[9] Menglin Jiang,et al. Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1 , 2020, OncoTargets and therapy.
[10] Z. Chen,et al. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] N. Cacalano,et al. Exosomes: Versatile Nano Mediators of Immune Regulation , 2019, Cancers.
[12] Ting Huyan,et al. MicroRNAs: Key Players in Bladder Cancer , 2019, Molecular Diagnosis & Therapy.
[13] M. Spahn,et al. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo , 2019, BMC Cancer.
[14] S. French,et al. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN. , 2019, Experimental and molecular pathology.
[15] X. Liu,et al. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). , 2019, Neoplasma.
[16] Liang Wang,et al. MicroRNA-186-5p represses neuroblastoma cell growth via downregulation of Eg5. , 2019, American journal of translational research.
[17] Zheng Xu,et al. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.
[18] J. Ge,et al. The functional potency of natural killer cells in response to IL‐2/IL‐15/IL‐21 stimulation is limited by a concurrent upregulation of Tim‐3 in bladder cancer , 2018, Experimental cell research.
[19] Si-ying Zhou,et al. Exosome: a novel mediator in drug resistance of cancer cells. , 2018, Epigenomics.
[20] John A. Taylor,et al. Metabolic changes in bladder cancer. , 2018, Urologic oncology.
[21] Jianhua Ruan,et al. Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer , 2018, Oncotarget.
[22] Wei Zhu,et al. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer , 2018, BMC Urology.
[23] L. Xia,et al. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1. , 2018, Archives of biochemistry and biophysics.
[24] Junling Shi,et al. Bifacial effects of engineering tumour cell‐derived exosomes on human natural killer cells , 2017, Experimental cell research.
[25] Raghu Kalluri,et al. Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.
[26] Yang Xia,et al. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway , 2017, Oncotarget.
[27] T. Stankovic,et al. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma , 2016, Oncotarget.
[28] E. N. Nolte-‘t Hoen,et al. Extracellular vesicles and viruses: Are they close relatives? , 2016, Proceedings of the National Academy of Sciences.
[29] Steven M Jay,et al. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery. , 2015, Molecular pharmaceutics.
[30] D. Iliopoulos,et al. Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells , 2015, Cellular and molecular gastroenterology and hepatology.
[31] E. Oltra. Relevance of Splicing on Tumor-Released Exosome Landscape: Implications in Cancer Therapeutics , 2014, Front. Endocrinol..
[32] Clotilde Théry,et al. Biogenesis and secretion of exosomes. , 2014, Current opinion in cell biology.
[33] G. Berchem,et al. The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity , 2013, Front. Immunol..
[34] Y. Miao,et al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer , 2013, Journal of Translational Medicine.
[35] Ting Huyan,et al. Effects of simulated microgravity on primary human NK cells. , 2013, Astrobiology.
[36] J. Akers,et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies , 2013, Journal of Neuro-Oncology.
[37] T. Whiteside. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). , 2013, Biochemical Society transactions.
[38] B. Ursø,et al. Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A , 2012, PloS one.
[39] O. Mandelboim,et al. CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells , 2011, The Journal of experimental medicine.
[40] P. Altevogt,et al. Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.
[41] T. Whiteside,et al. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs. , 2011, Bulletin du cancer.
[42] G. Ball,et al. NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting , 2009, Clinical Cancer Research.
[43] K. Yamaguchi,et al. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis , 2009, Cancer Immunology, Immunotherapy.
[44] M. Mason,et al. Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression1 , 2008, The Journal of Immunology.
[45] M. Weller,et al. TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells , 2006 .
[46] Aled Clayton,et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.
[47] M. Weller,et al. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. , 2006, Brain : a journal of neurology.
[48] D. Taylor,et al. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects , 2005, British Journal of Cancer.
[49] N. Minato,et al. Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer , 2005, Cancer Immunology, Immunotherapy.
[50] J. Zeuthen,et al. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: Decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells , 1990, Journal of Clinical Immunology.
[51] S. Ferrone,et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. , 2002, Cancer research.
[52] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[53] S. Natsugoe,et al. Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. , 2000, Cancer letters.
[54] M. A. Sáez,et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma , 1997, Cancer.
[55] M. Álvarez-Mon,et al. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. , 1990, The Journal of urology.